Project Grant D71TW011249

The United States Agency for International Development (USAID) Bureau for Global Health awarded a cooperative agreement totaling $78,980,821 to DAI Global LLC, doing business as DAI, to improve the capacity of countries in high-risk areas to respond to outbreaks of emergent zoonotic diseases in Uganda. The purpose of this agreement was to enhance Uganda's ability to detect and respond to zoonotic disease outbreaks from 2009 to 2014 through USAID's Foreign Assistance for Programs Overseas...

This $302,142 Project Grant awarded by the Fogarty International Center (CFDA 93.989 - International Research and Research Training) aims to strengthen the capacity of researchers in Uganda to conduct HIV treatment and prevention clinical trials in perinatal, pediatric, adolescent, and at-risk populations, including women and their partners. The grant recipient, Mu-Jhu Care LTD, an international organization based in Kampala, Uganda, will establish a training center to offer short-term,...

The Department of Health and Human Services' Fogarty International Center has awarded a $303,316 Project Grant under the CFDA 93.989 International Research and Research Training program to Makerere University College of Health Sciences in Uganda. The grant, titled "Harnessing Health Data Science Capacity to Strengthen Evidence-Based Interventions, Policy and Response to the HIV/AIDS Epidemic in Uganda (H-DATA)", aims to train Ugandan scientists and healthcare practitioners in health...

The federal Project Grant award of $101,290 from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) aims to strengthen grants administration capacity at the Makerere University College of Health Sciences in Uganda. The key products and services to be delivered under this award include: Providing advanced training and mentorship to senior research administrators at Makerere University on best practices for pre- and post-award...

This Project Grant award of $193,631 from the Fogarty International Center (CFDA 93.989 - International Research and Research Training) will support the "Scaling Up Advanced Genomics and Bioinformatics Research Training in Pediatric HIV/AIDS in Uganda - SURGE" program. The program aims to increase the pool of highly trained and skilled independent genomics and bioinformatics scientists to conduct research in pediatric HIV in Uganda. Key products and services to be delivered include:...

The Fogarty International Center (FIC), part of the National Institutes of Health (NIH), awarded a $268,665 project grant to the Joint Clinical Research Centre (JCRC) in Uganda under the International Research and Research Training program (CFDA 93.989). The grant, titled "Leveraging North-South Partnerships to Advance Cell and Gene Therapy for HIV Research Training Capacity in Uganda (C and GT-Uganda)," aims to strengthen research training capacity for cell and gene therapy approaches...

The Fogarty International Center (FIC) of the National Institutes of Health awarded a $100,720 Project Grant under the International Research and Research Training program (CFDA 93.989) to The Infectious Diseases Institute Limited (IDI) in Uganda. The grant, titled "HIGH-PERFORMANCE COMPUTING FOR HIV RESEARCH EXCELLENCE (HPC4HIV)", aims to strengthen IDI's capacity to support Ugandan biomedical research, particularly HIV research, by training four local staff in high-performance...

The Fogarty International Center (FIC) under the U.S. Department of Health and Human Services awarded a $124,524 Project Grant under the International Research and Research Training program (CFDA 93.989) to Makerere University Lung Institute Limited in Uganda. The grant supports research led by Dr. Alex Kayongo, MD-PhD, aimed at uncovering the relationship between the airway microbiome and immune response in people living with HIV who develop chronic obstructive pulmonary disease (COPD). Through...

This Project Grant award in the amount of $431,712, funded by the National Institute of Allergy and Infectious Diseases under the Allergy and Infectious Diseases Research program (CFDA 93.855), aims to improve HIV testing among children under five in rural Uganda. The primary goal is to engage with traditional healers to facilitate HIV counseling and testing via oral swab antigen tests for this vulnerable pediatric population. The award supports two key activities: 1) determining barriers and...

The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $690,538 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to the University of Washington for the project "EXPANDING ACCESS AND IMPACT OF TUBERCULOSIS PREVENTIVE THERAPY: COMMUNITY-FRIENDLY DELIVERY AND MONITORING OF TPT TO IMPROVE UPTAKE AND REDUCE TB TRANSMISSION." The project aims to explore new, person-friendly models of tuberculosis preventive therapy (TPT) delivery to...